MEREO BIOPHARMA GROUP PLC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

MREO

organization

Jurisdiction: GBLegal Form: B6ES

ACTIVE

LEI: 213800U8JQHIJOS5AS09SIC: 2834

Also known as: Mereo BioPharma Group plc

SEC Insider

$11.3M

139 transactions

Summary

MEREO BIOPHARMA GROUP PLC (MREO) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: —Sales: $3.1M15 insiders

Date	Insider	Type	Value
2026-02-26	WYZGA MICHAEL S	A	$0
2026-02-26	PAKIANATHAN DEEPIKA	A	$0
2026-02-26	Ekblom Anders	A	$0
2026-02-26	Ekblom Anders	A	—
2026-02-26	Shames Daniel	A	$0
2026-02-26	Shames Daniel	A	—
2026-02-26	Yoskowitz Marc J	A	$0
2026-02-26	Yoskowitz Marc J	A	—
2026-02-26	Jacquet Pierre	A	$0
2026-02-26	Jacquet Pierre	A	—
2026-02-26	Jenkins Annalisa	A	$0
2026-02-26	Jenkins Annalisa	A	—
2026-02-26	Bender Jeremy	A	$0
2026-02-26	Bender Jeremy	A	—
2026-02-01	Fox Christine Ann(Chief Financial Officer)	A	$0
2026-02-01	Fox Christine Ann(Chief Financial Officer)	A	$0
2026-02-01	Fox Christine Ann(Chief Financial Officer)	A	$0
2026-02-01	Scots-Knight Denise(Chief Executive Officer)	A	$0
2026-02-01	Scots-Knight Denise(Chief Executive Officer)	A	$0
2026-02-01	Scots-Knight Denise(Chief Executive Officer)	A	$0

Legal entity: GLEIF

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

MEREO BIOPHARMA GROUP PLC — Contributions, Lobbying & Contracts | Poliscope